Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (5967)	11/25/1998 9:01:00 AM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

Dauntless, You are truly remarkable. How I could make your point by detailing the fact that Z-Max sales in the third quarter were non-existent is beyond comprehension. But ultimately you miss my point. I'm not carrying some cross. I'm not out to paint a horrible picture (others have done that). I'm just trying to make sure the truth is told when it needs to be. So, when you suggest to readers in this forum that no royalties from product sales after channel fill is no big deal, I'm pointing out that it is a big deal. Who is right? I don't know, but it is important because the truth has been twisted (35% market share? that's a lie). And you are right that I do have alot to "bitch" about (especially with drug companies). I'm glad you have made money in this stock. I hope that you take some of that newfound wealth, and in the spirit of holiday cheer, spread the wealth in your family, friends and community. Tokyo